(VIANEWS) – Shares of EUROAPI (CAC 40: EAPI.PA) fell by a staggering 28.72% in 21 sessions from €15.6 to €11.12 at 10:54 EST on Friday, after two successive sessions in a row of losses. CAC 40 is rising 0.84% to €7,085.06, following the last session’s upward trend.
About EUROAPI
Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.
Volume
Today’s last reported volume for EUROAPI is 57624 which is 52% below its average volume of 288228.
Volatility
EUROAPI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.23%, a negative 2.26%, and a positive 2.08%.
EUROAPI’s highest amplitude of average volatility was 3.17% (last week), 3.43% (last month), and 2.08% (last quarter).
More news about EUROAPI (EAPI.PA).